Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial

The monthly continuous erythropoietin receptor activator (CERA) utilization maintains stable hemoglobin (Hb) after conversion from weekly epoetin-β (EB); however, how the different pharmacologic properties affect the red blood cell (RBC) size determined by RBC distribution width (RDW) has not been e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of hematology 2021-12, Vol.10 (6), p.255-265
Hauptverfasser:	Uriol-Rivera, Miguel G, Obrador-Mulet, Aina, Jimenez-Mendoza, Sonia, Corral-Baez, Antonio, Perianez-Parraga, Leonor, Garcia-Alvarez, Angel, de la Prada, Francisco J
Format:	Artikel
Sprache:	eng
Schlagworte:	Original
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!